Status:
COMPLETED
CI-AKI in Patients With Stable CAD and Comorbidities. Are we Doing Better?
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University
Conditions:
Stable Angina
Acute Kidney Injury
Eligibility:
All Genders
18-89 years
Brief Summary
Patients aged 18-89 with stable CAD and comorbidities receiving optimal medical treatment requiring PCI with iodinated contrast media. The aim of the study is to assess the prevalence of contrast-ind...
Eligibility Criteria
Inclusion
- Informed consent
- Male and female patients 18 y. o. and older
- Verified stable coronary artery disease (CAD)
- Receiving optimal medical treatment and requiring percutaneous coronary intervention (PCI) with iodinated contrast media
Exclusion
- Pregnancy, lactation
- Conditions affecting the prognosis (kidney failure, liver failure, oncology)
- Acute coronary syndrome (ACS)
- Stroke
- Contraindications to PCI
- Therapy with nephrotoxic drugs during the enrolment which cannot be stopped
- Refusal to sign the informed consent
Key Trial Info
Start Date :
May 16 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 12 2018
Estimated Enrollment :
1023 Patients enrolled
Trial Details
Trial ID
NCT04014153
Start Date
May 16 2012
End Date
December 12 2018
Last Update
October 29 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.